EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSEEEG00000023284
Gene Symbol: DHCR24
4 Cross references
209 Possible Orthologues:

26s Proteasome Regulatory Subunit 4

Ensembl ID : ENSEEEG00000010212
Gene Symbol: LOC113571724
4 Cross references
308 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase A

Ensembl ID : ENSEEEG00000013740
Gene Symbol: HMGCRA
4 Cross references
154 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Like

Ensembl ID : ENSEEEG00000001950
Gene Symbol: LOC113573726
4 Cross references
206 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1a

Ensembl ID : ENSEEEG00000000861
Gene Symbol: PDPK1A
4 Cross references
172 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1b

Ensembl ID : ENSEEEG00000010835
Gene Symbol: PDPK1B
4 Cross references
222 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase B

Ensembl ID : ENSEEEG00000023390
Gene Symbol: HPDB
2 Cross references
207 Possible Orthologues:

40s Ribosomal Protein S26

Ensembl ID : ENSEEEG00000002358
Gene Symbol: LOC113581557
4 Cross references
379 Possible Orthologues:

40s Ribosomal Protein S5

Ensembl ID : ENSEEEG00000016853
Gene Symbol: LOC113589072
3 Cross references
195 Possible Orthologues:

5'-Nucleotidase, Ecto (Cd73)

Ensembl ID : ENSEEEG00000012171
Gene Symbol: NT5E
2 Cross references
206 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1a B

Ensembl ID : ENSEEEG00000007428
Gene Symbol: HTR1AB
4 Cross references
138 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2b, G Protein-Coupled

Ensembl ID : ENSEEEG00000014149
Gene Symbol: HTR2B
2 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).